Klingelhutz A J, Hedrick L, Cho K R, McDougall J K
Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA.
Oncogene. 1995 Apr 20;10(8):1581-6.
Loss of heterozygosity and loss of expression of the deleted in colon cancer (DCC) gene is frequently observed in a number of different cancer types. To determine if the DCC gene plays a direct role in tumor suppression, wild-type full-length or truncated DCC cDNA constructs were transfected into nitrosomethylurea (NMU) transformed tumorigenic HPV-immortalized human epithelial cells that had allelic loss and reduced expression of DCC. Full-length DCC suppressed tumorigenicity whereas truncated DCC did not. Tumorigenic reversion of initially suppressed transfectants was associated with loss of DCC expression and loss or rearrangement of transfected DCC sequences. These results provide the first direct evidence that DCC is a tumor suppressor gene.
在许多不同类型的癌症中,经常观察到杂合性缺失以及结肠癌缺失基因(DCC)的表达缺失。为了确定DCC基因是否在肿瘤抑制中起直接作用,将野生型全长或截短的DCC cDNA构建体转染到具有DCC等位基因缺失和表达降低的亚硝基甲基脲(NMU)转化的致瘤性人乳头瘤病毒永生化上皮细胞中。全长DCC抑制了致瘤性,而截短的DCC则没有。最初被抑制的转染子的致瘤性逆转与DCC表达缺失以及转染的DCC序列缺失或重排有关。这些结果提供了首个直接证据,证明DCC是一种肿瘤抑制基因。